Page last updated: 2024-11-03

quipazine and Paralysis

quipazine has been researched along with Paralysis in 2 studies

Quipazine: A pharmacologic congener of serotonin that contracts smooth muscle and has actions similar to those of tricyclic antidepressants. It has been proposed as an oxytocic.

Paralysis: A general term most often used to describe severe or complete loss of muscle strength due to motor system disease from the level of the cerebral cortex to the muscle fiber. This term may also occasionally refer to a loss of sensory function. (From Adams et al., Principles of Neurology, 6th ed, p45)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ung, RV1
Landry, ES1
Rouleau, P1
Lapointe, NP1
Rouillard, C1
Guertin, PA1
White, SR1
Bieger, D1

Other Studies

2 other studies available for quipazine and Paralysis

ArticleYear
Role of spinal 5-HT2 receptor subtypes in quipazine-induced hindlimb movements after a low-thoracic spinal cord transection.
    The European journal of neuroscience, 2008, Volume: 28, Issue:11

    Topics: Animals; Disease Models, Animal; Hindlimb; Male; Mice; Motor Activity; Movement; Nerve Net; Paralysi

2008
Central serotonin receptor sensitivity in rats with experimental allergic encephalomyelitis.
    Research communications in chemical pathology and pharmacology, 1980, Volume: 30, Issue:2

    Topics: 5-Hydroxytryptophan; Animals; Brain Stem; Deglutition; Encephalomyelitis, Autoimmune, Experimental;

1980